PMID- 18243629 OWN - NLM STAT- MEDLINE DCOM- 20080630 LR - 20200106 IS - 0736-5748 (Print) IS - 0736-5748 (Linking) VI - 26 IP - 3-4 DP - 2008 May-Jun TI - Neuroprotection of brain-derived neurotrophic factor against hypoxic injury in vitro requires activation of extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. PG - 363-70 LID - 10.1016/j.ijdevneu.2007.11.005 [doi] AB - Intrauterine asphyxia is one of the major contributors for perinatal death, mental and physical disorders of surviving children. Brain-derived neurotrophic factor (BDNF) provides a promising solution to hypoxic injury due to its survival-promoting effects. In an attempt to identify possible molecular mechanisms underlying the neuroprotective role of BDNF, we studied extracellular signal-regulated kinase (ERK), phosphatidylinositol 3-kinase (PI-3-K) and p38 mitogen-activated protein kinase (MAPK) pathways. We demonstrated that BDNF protected cortical neurons against hypoxic injury in vitro via activation of both the ERK and PI-3-K pathways but not the p38 MAPK pathway. We also showed that both hypoxic stimuli and exogenous BDNF treatment phosphorylated the cyclic AMP response element-binding protein (CREB) and that CREB phosphorylation induced by BDNF was mediated via the ERK pathway in cultured cortical neurons. FAU - Sun, Xiaomei AU - Sun X AD - Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, PR China. FAU - Zhou, Hui AU - Zhou H FAU - Luo, Xiaoli AU - Luo X FAU - Li, Shengfu AU - Li S FAU - Yu, Dan AU - Yu D FAU - Hua, Jiping AU - Hua J FAU - Mu, Dezhi AU - Mu D FAU - Mao, Meng AU - Mao M LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20071217 PL - United States TA - Int J Dev Neurosci JT - International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience JID - 8401784 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Cyclic AMP Response Element-Binding Protein) RN - 0 (Enzyme Inhibitors) RN - 0 (Neuroprotective Agents) RN - EC 2.7.1.- (Phosphatidylinositol 3-Kinases) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinase 3) SB - IM MH - Animals MH - Brain/*enzymology/physiopathology MH - Brain-Derived Neurotrophic Factor/*pharmacology MH - Cells, Cultured MH - Cerebral Cortex/drug effects/enzymology/physiopathology MH - Cyclic AMP Response Element-Binding Protein/drug effects/metabolism MH - Enzyme Activation/drug effects MH - Enzyme Inhibitors/pharmacology MH - Female MH - Fetal Hypoxia/*enzymology/physiopathology MH - Hypoxia-Ischemia, Brain/drug therapy/*enzymology/physiopathology MH - Mitogen-Activated Protein Kinase 3/*metabolism MH - Neurons/drug effects/enzymology MH - Neuroprotective Agents/pharmacology MH - Phosphatidylinositol 3-Kinases/*metabolism MH - Phosphorylation/drug effects MH - Pregnancy MH - Rats EDAT- 2008/02/05 09:00 MHDA- 2008/07/01 09:00 CRDT- 2008/02/05 09:00 PHST- 2007/09/19 00:00 [received] PHST- 2007/11/16 00:00 [revised] PHST- 2007/11/29 00:00 [accepted] PHST- 2008/02/05 09:00 [pubmed] PHST- 2008/07/01 09:00 [medline] PHST- 2008/02/05 09:00 [entrez] AID - S0736-5748(07)00177-3 [pii] AID - 10.1016/j.ijdevneu.2007.11.005 [doi] PST - ppublish SO - Int J Dev Neurosci. 2008 May-Jun;26(3-4):363-70. doi: 10.1016/j.ijdevneu.2007.11.005. Epub 2007 Dec 17.